Clinical Trials Sponsored by The Institut Guttmann

Total 5053 results

Hellenic Institute for the Study of Sepsis

Completed

Pulse Photoplethysmography as an Early Tool for the Diagnosis of Sepsis (PROUD-1)

Sepsis

Greece
Hellenic Institute for the Study of Sepsis

Completed

A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis (PROVIDE)

Sepsis | Macrophage Activation Syndrome

Greece
Hellenic Institute for the Study of Sepsis

Completed

A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis (PROGRESS)

Sepsis

Greece
S.M.Chang, MD
The Methodist Hospital Research Institute

Completed

Reducing Radioisotope Dose: the Half-Dose CZT Study

Coronary Artery Disease

United States
The Netherlands Cancer Institute
Dutch Cancer Society

Completed

Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms

Breast Cancer Survivors | Climacteric Symptoms

Netherlands
Mayo Clinic
The Gertner Institute; ReAbility Online

Completed

Evaluation of a Tele-Rehabilitation Service Program

Stroke | Paresis

United States
The Cleveland Clinic
National Eye Institute (NEI)

Completed

PIONEER: Intraoperative and Perioperative OCT Study (PIONEER)

Retinal Detachment | Epiretinal Membrane | Fuchs Endothelial Dystrophy | Macular Hole

United States
The Netherlands Cancer Institute
Astellas Pharma Inc

Completed

Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation (DARANA)

Prostate Cancer | Androgen Receptor Abnormal | DNA
The Netherlands Cancer Institute
Bristol-Myers Squibb

Completed

Nivolumab in Patients With Recurrent Malignant Mesothelioma (NivoMes)

Malignant Pleural Mesothelioma
The Advanced Gynecologic Surgery Institute
Medtronic - MITG

Withdrawn

a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. (VLocmyo)

Infertility | Uterine Fibroids

United States
The George Institute for Global Health, China

Completed

Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 (CPACS-3)

Acute Coronary Syndromes

China
The Methodist Hospital Research Institute
Schering-Plough

Terminated

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

Carcinoma, Renal Cell

United States
The Methodist Hospital Research Institute
Oxford BioMedica

Completed

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Prostatic Neoplasms

United States
Rothman Institute Orthopaedics
The Anderson Orthopaedic Clinic

Completed

A Prospective, Randomized Trial Comparing Same Day Discharge and Overnight Hospital Stay Among Total Hip Arthroplasties Done by the Direct Anterior Approach

Osteoarthritis of the Hip

United States
The George Institute for Global Health, Australia

Completed

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS)

Critical Care, Fluid Resuscitation

Australia
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
The Cleveland Clinic

Completed

Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
The Cleveland Clinic

Withdrawn

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell Neoplasm

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Long Term Use of the Provox Vega 22.5

Total Laryngectomy

Netherlands
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy (N08HME)

Total Laryngectomy

Netherlands
Vardalinstitutet The Swedish Institute for Health...

Unknown

Supported Employment in a Swedish Context

Psychosis

Sweden
The George Institute
ANZICS Clinical Trials Group

Completed

Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

Acute Renal Failure

Australia
Quadram Institute Bioscience
The Coca-Cola Company

Completed

Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink

Iron Deficiency

United Kingdom
Hellenic Institute for the Study of Sepsis

Recruiting

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome (PRECISION)

Long COVID | Post-Acute COVID-19 | Post-Acute COVID-19 Syndrome

Germany, Greece, Italy, Spain
Hellenic Institute for the Study of Sepsis

Recruiting

Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial) (MODIFY)

Sepsis

Greece
The Methodist Hospital Research Institute
Novartis Pharmaceuticals

Recruiting

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Metastatic Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Metaplastic Breast Carcinoma

United States
Vejle Hospital
The Ottawa Hospital Research Institute

Recruiting

Impact of a Patient Decision Aid Intervention (IMPACTT)

Cancer, Breast | Cancer Colorectal

Denmark
The Methodist Hospital Research Institute
Genentech, Inc.

Not yet recruiting

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

Hepatocellular Carcinoma | Hepatocellular Cancer

United States
The Methodist Hospital Research Institute
Genentech, Inc.

Recruiting

Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy

Non-small Cell Lung Cancer

United States
The George Institute
George Clinical Pty Ltd

Recruiting

Global Kidney Patient Trials Network

Kidney Diseases

Australia
Dipan Shah

Recruiting

DeBakey Cardiovascular Magnetic Resonance Study (DEBAKEY-CMR)

Cardiovascular Diseases

United States
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients (TONIC-2)

Metastatic Breast Cancer

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO (BELLINI)

Breast Cancer

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC

NSCLC Stage IV

Netherlands
The Netherlands Cancer Institute
Hoffmann-La Roche

Recruiting

Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) (PANDA)

Stomach Cancer | Gastro Esophageal Junction Cancer

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer (NICHE)

Colon Carcinoma

Netherlands
ResMed
CRI-The Clinical Research Institute GmbH

Recruiting

HomeVent ( Connect) Registry: EU COPD Home NIV Registry (HOmeVent)

Chronic Obstructive Pulmonary Disease

Germany
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC (Indi-Blade)

Bladder Cancer | Urothelial Carcinoma

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma (NADINA)

Malignant Melanoma Stage III

United States, Netherlands, Australia
Hellenic Institute for the Study of Sepsis

Completed

Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO (CRONUS)

Respiratory Tract Infections | Bacterial Infections | Viral Infection | Multi-antibiotic Resistance

Greece
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
The Methodist Hospital Research Institute
Kaiser Permanente

Active, not recruiting

Explore Transplant @Home Within Kaiser Permanente Southern California

End Stage Renal Disease

United States
Hellenic Institute for the Study of Sepsis

Completed

Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection (BEYOND)

Mortality | Clostridioides Difficile Infection | Organ Dysfunction Syndrome | Stool Microbiome | Clostridioides Difficile Infection Recurrence

Greece
Hellenic Institute for the Study of Sepsis

Completed

Addressing Personalized Needs in Clostridioides Difficile Infection (BEYOND)

Clostridioides Difficile Infection

Greece
The Netherlands Cancer Institute
Dutch Cancer Society

Withdrawn

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Lung Cancer | Surgery | Circulating Tumor Cell

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Completed

Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy (NABUCCO)

Urothelial Carcinoma

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Terminated

Early Response Evaluation in NSCLC Patients Treated With Immunotherapy

NSCLC, Stage IV

Netherlands
The Netherlands Cancer Institute
Roche Pharma AG

Completed

ctDNA Guided Treatment of Early Resistance to Targeted Treatment (TATIN)

Carcinoma, Non-Small-Cell Lung

Netherlands

Clinical Trials Sponsored by The Institut Guttmann

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations